Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Equity - (Unaudited)

v3.22.1
Consolidated Statements of Equity - (Unaudited) - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjusted Balance
Common Stock
Common Stock
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Additional paid-in capital
Additional paid-in capital
Cumulative Effect, Period of Adoption, Adjustment
Additional paid-in capital
Cumulative Effect, Period of Adoption, Adjusted Balance
Retained earnings
Retained earnings
Cumulative Effect, Period of Adoption, Adjusted Balance
Noncontrolling interests
Noncontrolling interests
Cumulative Effect, Period of Adoption, Adjusted Balance
Beginning balance (in shares) at Dec. 31, 2020 32,600,000     1,000 32,556,303 32,557,303              
Beginning balance at Dec. 31, 2020 $ 529,486 $ 0 $ 529,486 $ 0 $ 3 $ 3 $ 496,174 $ (3) $ 496,171 $ 32,011 $ 32,011 $ 1,301 $ 1,301
Increase (Decrease) in Shareholders' Equity                          
Recapitalization transaction, net of fees and deferred taxes (in shares)       13,673,722                  
Recapitalization transaction, net of fees and deferred taxes 31,882     $ 2     31,880            
Stock-based compensation expense 2,376           2,376            
Net income (loss) (7,086)                 (7,074)   (12)  
Ending balance (in shares) at Mar. 31, 2021       46,231,025                  
Ending balance at Mar. 31, 2021 $ 556,658     $ 5     530,427     24,937   1,289  
Beginning balance (in shares) at Dec. 31, 2021 46,281,091     46,281,091                  
Beginning balance at Dec. 31, 2021 $ 621,397     $ 5     535,345     84,797   1,250  
Increase (Decrease) in Shareholders' Equity                          
Shares issued under share based awards (in shares)       204,065                  
Cash paid for shares withheld for taxes (672)           (672)            
Stock-based compensation expense $ 518           518            
Repurchase of common stock (in shares) 437,828     (437,828)                  
Repurchase of common stock $ (3,824)           (3,824)            
Net income (loss) $ 13,061                 13,065   (4)  
Ending balance (in shares) at Mar. 31, 2022 46,047,328     46,047,328                  
Ending balance at Mar. 31, 2022 $ 630,480     $ 5     $ 531,367     $ 97,862   $ 1,246